NEOFARM SEVERO-ZAPAD, OOO, Moscow

Accounting reports

Previously

Name	NEOFARM SEVERO-ZAPAD, OOO
INN	7731334851
KPP	773401001
OGRN	5167746314918
OKPO	05517162
Address	123423, G.MOSKVA, pr-kt. Marshala zhukova, d. 43, pomesch. 3/1 ETAZH 2

Extract from EGRUL $12 (€10)

Last name, first name & patronymic of the General Director

List of founders

Position of the company

Licenses

Authorized capital

Branches

Complete structure of the extract

Download an extract from EGRUL

We guarantee to provide you with an actual
information extract

OKVED code	Type	Name of activity type
Data on types of economic activities NEOFARM SEVERO-ZAPAD, OOO according to EGRUL
47.73	Core activity	Retailing drugs in specialized stores (pharmacies)
21.10	Additional activity	Manufacture of manmade fibres
21.20	Additional activity	Manufacturers of drugs and pharmaceuticals and medical products
All types of activities
46.18.1	Additional activity	Agents specialized in the wholesale trade of pharmaceutical products, products used for medical purposes, perfume and cosmetics, including soap and detergents
46.46	Additional activity	Wholesale of pharmaceutical goods
47.74	Additional activity	Retailing products used for medical purposes, orthopedic goods in specialized stores
47.75	Additional activity	Retailing of cosmetics and personal hygiene products in specialized stores
70.22	Additional activity	Advice on business and management
73.11	Additional activity	Activities of advertising agencies
73.20	Additional activity	Market research and public opinion polling
77.39.26	Additional activity	Rental and leasing of equipment, vehicles and other equipment used for medical purposes

Registration information

Registration date	10.11.2016

Description

NEOFARM SEVERO-ZAPAD, OOO (Moscow; INN 7731334851) was registered on 10 Nov 2016. The company's authorized capital as of July 1, 2012 was 10000 rub.

Principal activities of NEOFARM SEVERO-ZAPAD, OOO: retailing drugs in specialized stores (pharmacies) (47.73), manufacture of manmade fibres (21.10), manufacturers of drugs and pharmaceuticals and medical products (21.20).

Industry

Economic indicators

2023

Net profit (RAS) of NEOFARM SEVERO-ZAPAD, OOO grew over 2023 by 32.49% to 175.59 million RUB from 132.52 million RUB over 2022, the company informed.

Revenue increased in the accounting period by 23.75% to 13.45 billion RUB from 10.87 billion RUB over 2022; cost of goods sold grew by 21.13% to 10.63 billion RUB from 8.78 billion RUB; sales profit went up 1.52 times to 346.03 million RUB from 228.17 million RUB.

2022

Net profit (RAS) of NEOFARM SEVERO-ZAPAD, OOO grew over 2022 9.64 times to 132.52 million RUB from 13.74 million RUB over 2021, the company informed.

Revenue increased in the accounting period by 34.18% to 10.87 billion RUB from 8.10 billion RUB over 2021; cost of goods sold grew by 32.60% to 8.78 billion RUB from 6.62 billion RUB; sales profit went up 2.24 times to 228.17 million RUB from 101.74 million RUB.

2021

Net profit (RAS) of NEOFARM SEVERO-ZAPAD, OOO dropped in 2021 10.84 times to 13.74 million RUB from 148.97 million RUB over the same period in 2020, the company informed.

Revenue increased in the accounting period by 38.94% to 8.10 billion RUB from 5.83 billion RUB over 2020; cost of goods sold grew by 38.12% to 6.62 billion RUB from 4.79 billion RUB; sales profit fell 2.05 times to 101.74 million RUB from 208.61 million RUB.

2020

Net profit (RAS) of NEOFARM SEVERO-ZAPAD, OOO made up 148.97 million RUB over 2020 compared to net loss of 46.65 million RUB over 2019, the company informed.

Revenue increased in the accounting period 1.64 times to 5.83 billion RUB from 3.55 billion RUB over 2019; cost of goods sold grew 1.59 times to 4.79 billion RUB from 3.01 billion RUB; sales profit went up 11.40 times to 208.61 million RUB from 18.29 million RUB.

2019

Net loss (RAS) of NEOFARM SEVERO-ZAPAD, OOO dropped over 2019 3.19 times to 46.65 million RUB from 148.84 million RUB KAgent.Entities.Balance, the company informed.

Revenue increased in the accounting period 2.59 times to 3.55 billion RUB from 1.37 billion RUB over 2018; cost of goods sold grew 2.43 times to 3.01 billion RUB from 1.24 billion RUB; sales profit made up 18.29 million RUB compared to sales loss of 161.83 million RUB.

2018

Net loss (RAS) of NEOFARM SEVERO-ZAPAD, OOO increased 1.67 times to 148.84 million RUB from 89.15 million RUB over 2017, the company informed.

Revenue increased in the accounting period 4.11 times to 1.37 billion RUB from 334.04 million RUB over 2017; cost of goods sold grew 4.03 times to 1.24 billion RUB from 307.32 million RUB; sales loss grew 1.98 times to 161.83 million RUB from 81.93 million RUB.

2017

Net loss (RAS) of NEOFARM SEVERO-ZAPAD, OOO increased 119.35 times to 89.15 million RUB from 747.00 thousand RUB over 2016, the company informed.

Sales loss grew 117.20 times to 81.93 million RUB from 699.00 thousand RUB.

2016

Financial Highlights

Revenue and earnings data

Daily subscription $39 (€32)

unlimited access to database "Kontragent"

download any information within 24 hours

Pay online

Companies in the region

Guarantees

We guarantee

provision of
relevant
information

Payment methods

Statistics

Companies

12 336 456

Reports

17 430 600

Rrocessed requests

Extract from EGRUL:

Today, 4:14 AM

Accounting reports:

Today, 4:15 AM